Rapid response to single agent daratumumab is associated with improved progression-free survival in relapsed/refractory AL amyloidosis
Cohen, Oliver C., Brodermann, Maximillian H., Blakeney, Iona J., Mahmood, Shameem, Sachchithanantham, Sajitha, Ravichandran, Sriram, Law, Steven, Lachmann, Helen J., Whelan, Carol J., Popat, Rakesh, RJournal:
Amyloid
DOI:
10.1080/13506129.2020.1765768
Date:
May, 2020
File:
PDF, 1.11 MB
2020